Cancer research
Researchers at Sun Yat-sen University have found that overexpression of protein kinase C iota (PKCi) is associated with tumor aggressiveness and chemotherapy resistance in patients with colorectal cancer. In a retrospective analysis of patients with confirmed cancer diagnoses, the team found that PKCi overexpression was correlated with advanced clinical stage,
Cancer research
Researchers at the University of Michigan Rogel Cancer Center are nearing the recruitment phase for a Phase 2 clinical trial examining the effects of ovarian function suppression for breast cancer patients. The trial, led by principal investigator Norah L. Henry, aims to compare the efficacy of leuprolide at different doses
Cancer research
Researchers from the National Institute of Health and Medical Research have announced encouraging findings from the ICARUS-BREAST 01 study, which evaluated the efficacy and safety of patritumab deruxtecan (HER3-DXd) in patients with hormone receptor-positive metastatic breast cancer. The study involved 99 patients who had already received multiple treatments, including hormone
Cancer research
A study published in European Urology Open Science has made significant findings in the realm of penile cancer, indicating that certain biomarkers can serve as indicators for prognosis and treatment. Researchers at Orebro University in Sweden examined the expression of programmed cell death ligand 1 (PD-L1), T-cell immunoglobulin and immunoreceptor
Cancer research
Researchers at the University of Chinese Medicine have made a significant discovery in the fight against colon cancer, identifying a potential biomarker for early detection. The study, published in Discover Oncology, found that the B9D2 gene, essential for ciliary function, is significantly upregulated in colon cancer patients, making it a
Cancer research
Researchers at the National Clinical Research Center for Cancer have made significant strides in personalized medicine for lung adenocarcinoma, the most common subtype of non-small cell lung cancer. By analyzing transcriptomic and single-cell RNA sequencing data, the team identified an ac4C-related gene signature (ARGSig) that can predict survival outcomes and
Cancer research
Scientists from the Oil Crops Research Institute of the Chinese Academy of Agricultural Sciences have made a groundbreaking discovery in the fight against clubroot disease, a devastating affliction affecting cruciferous crops globally. The study, published in Nature Genetics, has identified a key susceptibility gene, GSL5, which can be hijacked by
Cancer research
Personalis, Inc., a leader in advanced genomics for precision oncology, has announced new data from an AstraZeneca phase 3 clinical trial in lung cancer, demonstrating that its highly sensitive molecular residual disease (MRD) test, NeXT Personal, is a strong predictor of outcomes in patients with stage II-IIIb, EGFR-mutated non-small cell
Cancer research
Researchers at the Netherlands Cancer Institute, led by Gordon Watt, have been awarded a prestigious European Research Council grant to investigate the interaction between autoimmune diseases and cancer treatments, with a focus on reducing the risk of developing second breast cancers. The study aims to leverage novel molecular approaches and
Cancer research
Researchers from Caris Life Sciences have developed a novel AI framework that achieves clinical-grade performance in detecting cancer biomarkers, particularly microsatellite instability (MSI)/mismatch repair deficiency (MMRd) and programmed death-ligand 1 (PD-L1), in colorectal and breast cancers. The study, published in Communications Medicine, reveals that patients with biomarker-positive model predictions
Cancer research
Researchers from the Third People's Hospital of Zhengzhou, Henan, China, have made a significant discovery in the treatment of non-small cell lung cancer (NSCLC). The study, recently published in Scientific Reports, reveals that combining neoadjuvant immunotherapy with chemotherapy can improve resection rates, survival, and progression-free survival in patients
Cancer research
Recent advances in immunotherapy and nanomedicine are paving the way for transformative strategies to penetrate the blood-brain barrier in pediatric central nervous system (CNS) tumors, a major challenge that limits therapeutic delivery and contributes to poor clinical outcomes. Researchers at Imam Mohammad Ibn Saud Islamic University have developed innovative nanocarrier
